Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 3 mins

Recruitment, Engagement, Experiences, and Self-Reported Changes in a Digital Patient Activation Intervention to Improve Hemodialysis Session Stability: Mixed Methods Study

AI Summary
  • Recruitment yielded 155 of 639 (24.3%); younger age, college graduation, and sleep disorders predicted enrolment.
  • 46.5% met a peer mentor and 37.4% completed all sessions; engagement higher in men, Black patients, recent dialysis vintage, and greater comorbidity.
  • Participants prioritised patient clinician communication and rated peer mentoring highly; digital patient activation strategies are needed to increase reach.
Summarise with AI (MRCPsych/FRANZCP)

J Med Internet Res. 2026 Oct 16;28:e93049. doi: 10.2196/93049.

ABSTRACT

BACKGROUND: When chronic kidney disease progresses to end-stage kidney disease, many patients receive in-center hemodialysis. Although lifesaving, hemodialysis is associated with intradialytic hypotension. Peer mentoring and patient activation support in hemodialysis have not been well studied.

OBJECTIVE: This Dialysafe study combined patient education and peer mentoring to promote health behaviors supporting prevention of intradialytic hypotension. We aimed to describe recruitment, engagement, completion, and attrition; assess participants’ health goals and self-reported behavior changes; and evaluate satisfaction and recommendations for improvement.

METHODS: At 10 Dialysafe hemodialysis centers assigned to patient activation, all eligible English-speaking patients were invited. The intervention comprised 5 educational modules and 5 videoconference peer-mentoring sessions. Mixed methods analyses integrated electronic health record and platform data, postintervention surveys, and clinic operations committee notes. An engagement score (range 0-50) summarized intervention use. Descriptive statistics, t tests, chi-square tests, logistic regression, and zero-inflated Poisson regression were used to assess recruitment, completion (all 5 mentoring sessions), and engagement. Qualitative data were inductively coded and integrated through joint displays.

RESULTS: Of the 639 eligible patients, 155 (24.3%) were recruited. Recruited patients were younger than nonrecruited patients (mean 57.6, SD 13.8, vs 64.3, SD 14.7 y; P<.001); each additional year was associated with 4% lower odds of recruitment (odds ratio [OR] 0.96, 95% CI 0.94-0.98; P<.001). Recruitment was more likely among college graduates (OR 1.70, 95% CI 1.02-2.83; P=.04) and patients with sleep disorders (OR 2.27, 95% CI 1.06-4.87; P=.03). Attrition was concentrated before mentoring sessions began. Of recruited patients, 72 of 155 (46.5%) met with a peer mentor and 58 of 155 (37.4%) completed all 5 sessions. Completers were 1.9 years younger (56.4, SD 13.8, vs 58.3, SD 13.9 y) and had Charlson Comorbidity Index scores 0.4 points higher (3.4, SD 2.0, vs 3.0, SD 2.3) than noncompleters. The average engagement score was 18.4 of 50 (SD 20.1). Engagement was higher among men (incidence rate ratio [IRR] 1.33, 95% CI 1.22-1.45; P<.001), Black patients (IRR 1.27, 95% CI 1.16-1.39; P<.001), and patients with dialysis vintage <1 year (IRR 1.22, 95% CI 1.05-1.42; P=.01). Higher Charlson Comorbidity Index scores predicted engagement (IRR 1.04, 95% CI 1.01-1.07; P=.002) and completion (OR 1.37, 95% CI 1.05-1.79; P=.02). Of 79 patients who set goals, 64 (81%) selected communication with the care team; 22 of 54 (40.7%) survey respondents identified this as their main behavior change. Both mentees and mentors identified peer-mentoring sessions as the most valuable component. Among mentee respondents, 55 of 55 (100%) respondents rated the program good or excellent, and 53 of 54 (98.1%) respondents would recommend it.

CONCLUSIONS: Participants constituted a self-selecting group. Patient-clinician communication was a priority, and participants valued peer mentoring. Digital patient activation intervention strategies to increase reach are needed.

TRIAL REGISTRATION: ClinicalTrials.gov NCT03171545; https://clinicaltrials.gov/ct2/show/NCT03171545.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/46187.

PMID:42887003 | DOI:10.2196/93049

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

←
RAISR4D CME/CPD Evidence Nodes
Explore previous RAISR4D CME/CPD evidence nodes.
CME/CPD